ALLO
Allogene Therapeutics, Inc. · Healthcare
Director Deborah M. Messemer sold $50K of Allogene Therapeutics, Inc.
Sold$50,317
$2.70Price
18,640Shares
−23%Stake
What ALLO did after the filing
- The stock from Wed, Dec 20 close, $2.78
- +48.9%
- S&P 500, same days
- +5.2%
Measured over 30 trading days, to the Feb 5 close.
Traded Mon, Dec 18. Filed Wed, Dec 20, 11:26 AM ET, during the session. Returns use the Dec 20 close and the Feb 5 close. Not investment advice.